Attila Tordai

6.7k total citations · 1 hit paper
121 papers, 4.6k citations indexed

About

Attila Tordai is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Attila Tordai has authored 121 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 41 papers in Hematology and 28 papers in Genetics. Recurrent topics in Attila Tordai's work include Drug Transport and Resistance Mechanisms (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (9 papers). Attila Tordai is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (9 papers). Attila Tordai collaborates with scholars based in Hungary, United States and France. Attila Tordai's co-authors include Lajos Pusztai, Cornelia Liedtke, Gabriel N. Hortobágyi, W. Fraser Symmans, Fabrice André, Ana M. González-Angulo, Marjorie Green, Bryan T. Hennessy, Jaime Mejia and Massimo Cristofanilli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Attila Tordai

116 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

2008 2.2k citations Cornelia Liedtke, Chafika Mazouni et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Attila Tordai Hungary	29	2.0k	1.7k	1.6k	701	583	121	4.6k
Francesco Hofmann Switzerland	30	1.4k 0.7×	1.0k 0.6×	4.2k 2.6×	572 0.8×	443 0.8×	56	5.9k
Timothy E. Kute United States	33	2.0k 1.0×	1.3k 0.8×	1.8k 1.1×	500 0.7×	221 0.4×	78	4.2k
Marco Danova Italy	30	1.6k 0.8×	634 0.4×	1.1k 0.7×	338 0.5×	413 0.7×	226	3.5k
Rebecca Elstrom United States	31	1.9k 1.0×	1.3k 0.7×	1.8k 1.1×	1.8k 2.6×	813 1.4×	83	5.4k
Laura K. Shawver United States	26	2.0k 1.0×	1.2k 0.7×	3.4k 2.1×	304 0.4×	386 0.7×	47	5.1k
Lawrence Panasci Canada	35	2.0k 1.0×	1.0k 0.6×	1.9k 1.2×	385 0.5×	431 0.7×	113	4.1k
Margaret Dugan United States	29	2.5k 1.2×	1.4k 0.8×	1.9k 1.2×	658 0.9×	2.2k 3.8×	71	6.2k
Bijoyesh Mookerjee United States	30	3.7k 1.8×	2.3k 1.3×	4.1k 2.5×	781 1.1×	533 0.9×	85	7.4k
Joseph Boni United States	28	1.8k 0.9×	822 0.5×	2.5k 1.5×	965 1.4×	766 1.3×	88	4.7k
Lynn C. Moscinski United States	31	2.0k 1.0×	996 0.6×	2.8k 1.7×	785 1.1×	642 1.1×	129	5.1k

Countries citing papers authored by Attila Tordai

Since Specialization

Citations

This map shows the geographic impact of Attila Tordai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Tordai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Tordai more than expected).

Fields of papers citing papers by Attila Tordai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Tordai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Tordai. The network helps show where Attila Tordai may publish in the future.

Co-authorship network of co-authors of Attila Tordai

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Tordai. A scholar is included among the top collaborators of Attila Tordai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Tordai. Attila Tordai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tõkés, Anna‐Mária, Rita Padányi, Béla Papp, et al.. (2025). The calcium pump PMCA4b promotes epithelial cell polarization and lumen formation. Communications Biology. 8(1). 421–421.

Németh, Bertalan, et al.. (2025). Systematic Literature Review on Economic Evaluations and Health Economic Models in Metastatic Castration-Sensitive Prostate Cancer. Current Oncology. 32(8). 412–412.

Naffa, Randa, Luca Hegedüs, Tamás Hegedűs, et al.. (2023). Plasma membrane Ca²⁺ pump isoform 4 function in cell migration and cancer metastasis. The Journal of Physiology. 602(8). 1551–1564. 5 indexed citations

Liedtke, Cornelia, Chafika Mazouni, Kenneth R. Hess, et al.. (2023). Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer. Journal of Clinical Oncology. 41(10). 1809–1815. 62 indexed citations

Telbisz, Ágnes, et al.. (2020). The transport pathway in the ABCG2 protein and its regulation revealed by molecular dynamics simulations. Cellular and Molecular Life Sciences. 78(5). 2329–2339. 21 indexed citations

Csanádi, Marcell, Tamás Ágh, Attila Tordai, et al.. (2019). A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology. 12(5). 311–323. 18 indexed citations

Varga, Gergely, Gábor Mikala, András Bors, et al.. (2017). The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma. 59(3). 710–716. 1 indexed citations

Dinya, Tamás, Tamás Tornai, Zsuzsanna Vitális, et al.. (2017). Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis. Liver International. 38(7). 1242–1252. 7 indexed citations

Kalmár, Lajos, et al.. (2011). Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia. Medical Oncology. 29(3). 2136–2142. 7 indexed citations

10.

Szilvási, Anikó, Hajnalka Andrikovics, Ákos Kalina, et al.. (2010). Frequencies of Four ATP-Binding Cassette Transporter G8 Polymorphisms in Patients with Ischemic Vascular Diseases. Genetic Testing and Molecular Biomarkers. 14(5). 667–672. 7 indexed citations

11.

Boussac, Hugues de, Marcin Ratajewski, Attila Tordai, et al.. (2010). The ERK1/2-Hepatocyte Nuclear Factor 4α Axis Regulates Human ABCC6 Gene Expression in Hepatocytes. Journal of Biological Chemistry. 285(30). 22800–22808. 37 indexed citations

12.

Andrikovics, Hajnalka, et al.. (2009). The R1141X Loss-of-Function Mutation of the ABCC6 Gene Is a Strong Genetic Risk Factor for Coronary Artery Disease. Genetic Testing and Molecular Biomarkers. 14(1). 75–78. 51 indexed citations

13.

André, Fabrice, Bastien Job, Philippe Dessen, et al.. (2009). Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array. Clinical Cancer Research. 15(2). 441–451. 248 indexed citations

14.

Liedtke, Cornelia, Luca Cardone, Attila Tordai, et al.. (2008). PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer. Breast Cancer Research. 10(2). R27–R27. 49 indexed citations

15.

Andrikovics, Hajnalka, Attila Tordai, Csongor Kiss, et al.. (2007). Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. The Pharmacogenomics Journal. 8(5). 321–327. 29 indexed citations

16.

Arányi, Tamás, Marcin Ratajewski, Viola Bardóczy, et al.. (2005). Identification of a DNA Methylation-dependent Activator Sequence in the Pseudoxanthoma Elasticum Gene, ABCC6. Journal of Biological Chemistry. 280(19). 18643–18650. 35 indexed citations

17.

Hunter, Michael, Évelyne Heyer, Frédéric Austerlitz, et al.. (2002). The P28T Mutation in the GALK1 Gene Accounts for Galactokinase Deficiency in Roma (Gypsy) Patients across Europe. Pediatric Research. 51(5). 602–606. 21 indexed citations

18.

Andrikovics, Hajnalka, et al.. (2001). Genotype Screening for Hereditary Hemochromatosis among Voluntary Blood Donors in Hungary. Blood Cells Molecules and Diseases. 27(1). 334–341. 15 indexed citations

19.

Tordai, Attila, et al.. (2001). [Platelet glycoprotein IIb/IIIa (LeuPro 33) polymorphism in stroke patients].. PubMed. 142(15). 781–5. 5 indexed citations

20.

Franklin, Richard A., Attila Tordai, Bruce Mazer, et al.. (1994). Activation of MAP2-kinase in B lymphocytes by calcium ionophores.. The Journal of Immunology. 153(11). 4890–4898. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact